Subcutaneous Biologics Market Global Forecasts to 2035: Leading Players & Sales Forecast for Adocia, Alteogen, Ascendis Pharma, CD Bioparticles, Creative Biolabs, Pacira Biosciences & Xeris Biopharma - ResearchAndMarkets.com

The "Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental Principle, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Leading Players and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.

The rising adoption of self-administration devices and technological advancements related to subcutaneous delivery of biologic drugs, is indicative of the growth of subcutaneous biologics market in the next decade. In recent years, the pharmaceutical industry has witnessed an increase in number of biologic drugs, such as gene therapies, blood products, cell products, antibodies, and protein therapeutics. Unlike traditional chemical-based medications, which are generally easier and relatively cheaper to develop, biologics pose unique challenges during the drug development process.

These challenges include high molecular weight, complex chemical structures, susceptibility to degradation after administration, and intricate manufacturing processes. To address these challenges, pharmaceutical companies are utilizing innovative technologies to develop biologics which are capable of treating a wide range of diseases. These technological advancements involve the formulation of subcutaneous biologics based on conjugation, amino acid modification, and encapsulation principles.

Furthermore, novel drug delivery systems such as autoinjectors, pre-filled syringes, and needle-free devices are actively being designed to deliver highly viscous formulations. Notably, a rise in biologic drugs approvals by the US Food and Drug Administration (FDA) was observed in the industry, with nine approvals in the first quarter of 2024. This growing shift towards biologics can be attributed to their potential in offering targeted treatments with minimal drug interactions.

Historically, intravenous administration of biologics was preferred, owing to their rapid systemic circulation and high bioavailability. Although intravenous administration is an effective method for biologics delivery, it requires frequent involvement of healthcare professionals, which can pose a challenge in terms of medication adherence. To circumvent these challenges, subcutaneous administration methods have emerged as suitable alternatives and have gained traction for their effectiveness, tolerability and safety. Furthermore, the shift towards subcutaneous biologics is driven by the increasing demand for self-administered therapies and the availability of user-friendly devices, such as autoinjectors and pre-filled syringes.

Key Benefits of Buying this Report

• The report offers valuable insights into revenue estimation for both the overall market and its sub-segments, in order to empower market leaders and newcomers with critical information requisite for establishing their footprint in the industry.
• The report can be utilized by stakeholders to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a comprehensive view on the Subcutaneous Biologics Market, covering essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Players Profiles include:

• Adocia
• Alteogen
• Ascendis Pharma
• CD Bioparticles
• Creative Biolabs
• Creative BioMart
• Foresee Pharmaceuticals
• Pacira Biosciences
• The Wyss Institute
• Xeris Biopharma

Key Topics Covered:

APPROVED SUBCUTANEOUS BIOLOGICS: MARKET LANDSCAPE

• Approved Subcutaneous Biologics: Overall Market Overview
• Approved Subcutaneous Biologics: List of Developers

APPROVED SUBCUTANEOUS BIOLOGICS: SUCCESS PROTOCOL ANALYSIS

Success Protocol Analysis of Top Approved Subcutaneous Biologics

• BENLYSTA (Human Genome Sciences)
• BESREMi (PharmaEssentia)
• COSENTYX (Novartis)
• DARZALEX FASPRO / DARZALEX SC (Halozyme)
• DUPIXENT (Regeneron Pharma)
• Enbrel (Amgen)
• HEMLIBRA (Roche)
• Prolia / Pralia (Amgen)
• STELARA (Janssen Biotech)
• Trulicity (Eli Lilly)

CLINICAL-STAGE SUBCUTANEOUS BIOLOGICS: MARKET LANDSCAPE

• Clinical-stage Subcutaneous Biologics: Overall Market Overview
• Clinical-stage Subcutaneous Biologics: List of Developers

SUBCUTANEOUS FORMULATION: TECHNOLOGY LANDSCAPE

• Subcutaneous Formulation: Technology Landscape
• Subcutaneous Formulation: Technology Developers Landscape

SUBCUTANEOUS FORMULATION TECHNOLOGY PROVIDERS: COMPANY PROFILES

Technology Developers Based in North America

• CD Bioparticles
• Creative Biolabs
• Creative BioMart
• Pacira BioSciences
• The Wyss Institute
• Xeris Biopharma

Technology Developers Based in Europe

• Adocia
• Ascendis Pharma

Technology Developers Based in Asia-Pacific

• Alteogen
• Foresee Pharmaceuticals

SUBCUTANEOUS FORMULATION TECHNOLOGIES: PARTNERSHIPS AND COLLABORATIONS

• Partnership Models
• Partnerships and Collaborations: Subcutaneous Formulation Technology
• Analysis by Geography

SUBCUTANEOUS DRUG DELIVERY SYSTEMS: MARKET LANDSCAPE

Types of Subcutaneous Drug Delivery Systems

• Large Volume Wearable Injectors
• Autoinjectors
• Pen Injectors
• Needle Free Injection System
• Novel Drug Reconstitution Delivery Systems
• Prefilled Syringes
• Implants

SUBCUTANEOUS DRUG DELIVERY SYSTEMS: PRODUCT COMPETITIVENESS ANALYSIS

• Large Volume Wearable Injectors
  • Autoinjectors
  • Needle-free Injection Systems
  • Prefilled Syringes

SWOT ANALYSIS

GLOBAL APPROVED SUBCUTANEOUS BIOLOGICS MARKET

• Global Approved Subcutaneous Biologics Market, till 2035

APPROVED SUBCUTANEOUS BIOLOGICS MARKET, BY TYPE OF BIOLOGIC

• Approved Subcutaneous Biologics Market: Distribution by Type of Biologic, Current year and 2035

APPROVED SUBCUTANEOUS BIOLOGICS MARKET, BY TYPE OF THERAPY

• Approved Subcutaneous Biologics Market: Distribution by Type of Therapy, Current year and 2035

APPROVED SUBCUTANEOUS BIOLOGICS MARKET, BY METHOD OF ADMINISTRATION

• Approved Subcutaneous Biologics Market: Distribution by Method of Administration, Current year and 2035

APPROVED SUBCUTANEOUS BIOLOGICS MARKET, BY THERAPEUTIC AREA

• Approved Subcutaneous Biologics Market: Distribution by Therapeutic Area, Current year and 2035

APPROVED SUBCUTANEOUS BIOLOGICS MARKET, BY GEOGRAPHICAL REGIONS

• Approved Subcutaneous Biologics Market: Distribution by Geographical Regions, Current year and 2035

APPROVED SUBCUTANEOUS BIOLOGICS MARKET, SALES FORECAST OF DRUGS

Drug-wise Sales Forecast

• Actemra / RoActemra
• Acthar Gel / ACTHar
• AIMOVIG
• AJOVY
• AMVUTTRA
• Aranesp / NESP
• Basaglar / Abasaglar
• BENLYSTA
• Betaseron / Betaferon / EXTAVIA
• CABLIVI
• CIMZIA
• COSENTYX
• CRYSVITA
• DARZALEX FASPRO / DARZALEX SC
• DUPIXENT
• EMGALITY
• Enbrel
• ENSPRYNG
• ENTYVIO
• Epogen / Procrit / Eprex
• EVENITY
• FASENRA
• FIASP
• Forteo / Forsteo
• GATTEX / Revestive
• Genotropin
• GIVLAARI
• G-LASTA / Peglasta / Neulasta / GRAN
• Gonal-F
• HAEGARDA
• HEMLIBRA
• Herceptin SC / HERCEPTINT HYLECTA
• Hizentra
• Humalog
• HUMIRA
• Humulin
• ILARIS
• Kesimpta
• KEVZARA
• KINERET
• LANTUS
• LEQVIO
• Mircera
• MOUNJARO
• NPLATE
• Nucala
• ORENCIA
• OXLUMO
• PALYNZIQ
• Phesgo
• PLEGRIDY
• PRALUENT
• Prolia / Pralia
• Rebif
• REBLOZYL
• REKOVELLE
• Repatha
• RITUXAN HYCELA / MabThera SC
• RYZODEG 70/30 SC
• Saizen
• Saxenda
• SIMPONI
• Skyrizi
• SOLIQUA 100/33
• STELARA
• Strensiq
• TAKHZYRO
• Taltz
• Tecentriq
• TEGSEDI
• TEZSPIRE
• Toujeo
• TREMFYA
• TRESIBA
• Trulicity
• Tysabri
• Ultomiris
• Victoza
• Voxzogo
• VYVGART Hytrulo
• WAINUAT
• Xgeva / RANMARK
• XOLAIR
• XULTOPHY
• ZEPBOUND

APPROVED SUBCUTANEOUS BIOLOGICS MARKET, BY LEADING PLAYERS

GLOBAL SUBCUTANEOUS BIOLOGICS FORMULATION TECHNOLOGIES MARKET

• Global Subcutaneous Biologics Formulation Technologies Market, till 2035

SUBCUTANEOUS BIOLOGICS FORMULATION TECHNOLOGIES MARKET, BY FUNDAMENTAL PRINCIPLE

• Subcutaneous Biologics Formulation Technologies Market: Distribution by Fundamental Principle, Current year and 2035

SUBCUTANEOUS BIOLOGICS FORMULATION TECHNOLOGIES MARKET, BY END USER

• Subcutaneous Biologics Formulation Technologies Market: Distribution by Type of End User, Current year and 2035

SUBCUTANEOUS BIOLOGICS FORMULATION TECHNOLOGIES MARKET, BY THERAPEUTIC AREA

• Subcutaneous Biologics Formulation Technologies Market: Distribution by Therapeutic Area, Current year and 2035

SUBCUTANEOUS BIOLOGICS FORMULATION TECHNOLOGIES MARKET, BY KEY GEOGRAPHICAL REGIONS

• Subcutaneous Biologics Formulation Technologies Market: Distribution by Key Geographical Regions, Current year and 2035

SUBCUTANEOUS BIOLOGICS FORMULATION TECHNOLOGIES MARKET, BY TYPE OF PAYMENT METHOD EMPLOYED

• Subcutaneous Biologics Formulation Technologies Market: Distribution by Type of Payment Method Employed, Current year and 2035

SUBCUTANEOUS BIOLOGICS FORMULATION TECHNOLOGIES MARKET, BY LEADING PLAYERS

For more information about this report visit https://www.researchandmarkets.com/r/87jabc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250121671890/en/